A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells

Cited by (191)

Items 101–191 of 191

1. The Janus face of HIF-1α in ischemic stroke and the possible associated pathways
   Nashwa Amin, Irum Naz Abbasi, Fei Wu, Zongjie Shi, Javaria Sundus, Azhar Badry, Xia Yuan, Bingxin Zhao, Jie Pan, Xiaodan Mi et al. · 2024 · Neurochemistry International
2. Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells
   Caixia Tang, Hu Lei, Jinfu Zhang, Meng Liu, Jin Jin, Hao Luo, Hanzhang Xu, Yingli Wu · 2018 · Cancer Biology & Therapy
3. A Hypoxia-Inflammation Cycle and Multiple Sclerosis: Mechanisms and Therapeutic Implications
   Ateyeh Soroush, Jeff F. Dunn · 2024 · Current Treatment Options in Neurology
4. The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment
   Markus Mandl, Maria- Katharina Lieberum, Juergen Dunst, Reinhard Depping · 2015 · Radiation Oncology
5. Modulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug Resistance
   Hoda Soleymani Abyaneh, Amir Soleimani, Mohammad Reza Vakili, Rania Soudy, Kamaljit Kaur, Francesco Cuda, Ali Tavassoli, Afsaneh Lavasanifar · 2018 · Pharmaceutics
6. TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation
   Giuseppina Bruno, Valeria Li Bergolis, Annamaria Piscazzi, Fabiana Crispo, Valentina Condelli, Pietro Zoppoli, Francesca Maddalena, Michele Pietrafesa, Guido Giordano, Danilo Swann Matassa et al. · 2022 · International Journal of Oncology
7. Intracellular Production of Cyclic Peptide Libraries with SICLOPPS
   Eliot L. Osher, Ali Tavassoli · 2016 · Methods in molecular biology
8. Rapid discovery of cyclic peptide protein aggregation inhibitors by continuous selection
   Linwei Yang, Jingwei Zhang, James S. Andon, Lingjun Li, Tina Wang · 2025 · Nature Chemical Biology
9. Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting
   Antonietta Rosella Farina, Lucia Annamaria Cappabianca, Veronica Zelli, Michela Sebastiano, Andrew Reay Mackay · 2021 · World Journal of Stem Cells
10. A bidirectional fluorescent two-hybrid system for monitoring protein–protein interactions
    Ida Karin Nordgren, Ali Tavassoli · 2013 · Molecular BioSystems
11. Hypoxia-inducible transcription factors: architects of tumorigenesis and targets for anticancer drug discovery
    Alexander McDermott, Ali Tavassoli · 2024 · Transcription
12. Synthesis and anticancer screening of some novel Pd-catalysed 3-methyl indole based analogues on Mia PaCa-2 cell line
    Abdul Rahman, N. Prashanth, B. N. Nippu, H M Kumaraswamy, A. N. Rajeshwara, Nayak Devappa Satyanarayan · 2022 · Journal of Molecular Structure
13. Understanding the relationship between cancer associated cachexia and hypoxia-inducible factor-1
    Subramanian Muthamil, Hyun Yong Kim, Hyun‐Jun Jang, Ji‐Hyo Lyu, Ung Cheol Shin, Younghoon Go, Seong‐Hoon Park, Hee Gu Lee, Jun Hong Park · 2023 · Biomedicine & Pharmacotherapy
14. Genetically Encoded Cyclic Peptide Libraries: From Hit to Lead and Beyond
    Jacob Valentine, Ali Tavassoli · 2018 · Methods in enzymology on CD-ROM/Methods in enzymology
15. Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110α
    Mohamed Ismail, Stephen R. Martin, Roger George, Francesca Houghton, Geoff P. Kelly, Raphaël A. G. Chaleil, Panayiotis Anastasiou, Xinyue Wang, Nicola O’Reilly, Stefania Federico et al. · 2023 · Scientific Reports
16. Differential suppression of the aryl hydrocarbon receptor nuclear translocator-dependent function by an aryl hydrocarbon receptor PAS-A-derived inhibitory molecule
    Jinghang Xie, Xin Huang, Miki S. Park, Hang Minh Pham, William K. Chan · 2014 · Biochemical Pharmacology
17. Total Synthesis and Biological Evaluation of Rakicidin A and Discovery of a Simplified Bioactive Analogue
    Michail Tsakos, Lise L. Clement, Eva S. Schaffert, Frank N. Olsen, Sebastiano Rupiani, Rasmus Djurhuus, Wanwan Yu, Kristian M. Jacobsen, Nikolaj L. Villadsen, Thomas Bjørnskov Poulsen · 2015 · Angewandte Chemie
18. Pseudohypoxic stabilization of HIF1α via cyclophilin D suppression promotes melanoma metastasis
    Hye‐Kyung Park, Sung Hu, So Yeon Kim, Sora Yoon, Nam Gu Yoon, Ji Hye Lee, Wonyoung Choi, Sun‐Young Kong, Jong Heon Kim, Dougu Nam et al. · 2025 · Signal Transduction and Targeted Therapy
19. Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy
    Mark J. de Keijzer, Daniel J. de Klerk, Lianne R. de Haan, Robert T. van Kooten, Leonardo Pereira Franchi, Lionel Mendes Dias, Tony G. Kleijn, Diederick J. van Doorn, Michal Heger, on behalf of the Photodynamic Therapy Study Group · 2022 · Methods in molecular biology
20. Peptide/protein-based macrocycles: from biological synthesis to biomedical applications
    Wenhao Wu, Jianwen Guo, Longshuai Zhang, Wenbin Zhang, Weiping Gao · 2022 · RSC Chemical Biology
21. N terminal N -methylation modulates chiral centre induced helical (CIH) peptides’ biophysical properties
    Wenjun Li, Kuan Hu, Qingzhou Zhang, Dongyuan Wang, Yue Ma, Zhanfeng Hou, Feng Yin, Zigang Li · 2018 · Chemical Communications
22. A robust platform streamlining aromatic noncanonical amino acid biosynthesis and genetic code expansion in Escherichia coli
    Jingxuan Zhang, Keying Yu, Yan Hai Xu, Wushuang Zhao, Yulian Li, Ying Wang, Florian P. Seebeck, Xiaohua Chen, Cangsong Liao · 2025 · Nature Communications
23. microRNA‑646 inhibits angiogenesis of endothelial progenitor cells in pre‑eclamptic pregnancy by targeting the VEGF‑A/HIF‑1α axis
    Dirong Dong, Yimin Khoong, Yunzhen Ko, Yuanzhen Zhang · 2020 · Experimental and Therapeutic Medicine
24. HIF-1 promotes the expression of its α-subunit via an epigenetically regulated transactivation loop
    Daniel J. Asby, Francesco Cuda, Franciane Hoakwie, E Miranda, Ali Tavassoli · 2014 · Molecular BioSystems
25. The Role of 2-Oxoglutarate-Dependent Oxygenases in Hypoxia Sensing
    Sarah E. Wilkins, Emily Flashman, John S. Scotti, Richard J. Hopkinson, Rasheduzzaman Chowdhury, Christopher John Schofield · 2015 · Royal Society of Chemistry eBooks
26. Interfacial Peptides as Affinity Modulating Agents of Protein-Protein Interactions
    Pavel V. Ershov, Yuri V. Mezentsev, Alexis S. Ivanov · 2022 · Biomolecules
27. Synthetic Peptide Libraries: From Random Mixtures to In Vivo Testing
    Annamaria Sandomenico, Andrea Caporale, Nunzianna Doti, Simon Cross, Gabriele Cruciani, Angela Chambery, Sandro De Falco, Menotti Ruvo · 2018 · Current Medicinal Chemistry
28. Understanding p300-transcription factor interactions using sequence variation and hybridization
    Fruzsina Hóbor, Zsófia Hegedüs, Amaurys Ávila Ibarra, Vencel László Petrovicz, Gail J. Bartlett, Richard Barry Sessions, Andrew John Wilson, Thomas A. Edwards · 2022 · RSC Chemical Biology
29. Evaluation of a novel monoclonal antibody mAb109 by immuno-PET/fluorescent imaging for noninvasive lung adenocarcinoma diagnosis
    Hua Zhu, Te-li Liu, Changhao Liu, Jing Wang, Hong Zhang, Bin Dong, Jing Shen, Chuanke Zhao, Zhen-fu Li, Zhen Cheng et al. · 2019 · Acta Pharmacologica Sinica
30. Next Generation SICLOPPS Screening for the Identification of Inhibitors of the HIF-1α/HIF-1β Protein–Protein Interaction
    Alexander McDermott, Leonie M. Windeln, Jacob S. D. Valentine, Leonardo Baldassarre, Andrew D. Foster, Ali Tavassoli · 2024 · ACS Chemical Biology
31. Stereochemistry Rules: A Single Stereocenter Changes the Conformation of a Cyclic Tetrapeptide
    Fee Li, Kenny Bravo‐Rodriguez, Miguel Fernández‐Oliva, Juan Manuel Ramírez‐Anguita, Klaus Merz, Manuela V. Winter, Christian W. Lehmann, Wolfram Sander, Elsa Sánchez‐García · 2013 · The Journal of Physical Chemistry B
32. Directed evolution of enzymes
    Fábio K. Tamaki · 2020 · Emerging Topics in Life Sciences
33. Targeting transcription factors in cancer drug discovery
    Partha Mitra · 2020 · Exploration of Targeted Anti-tumor Therapy
34. Designing Orally Bioavailable Peptide and Peptoid Macrocycles
    David A. Price, Alan M. Mathiowetz, Spiros I. Liras · 2017
35. Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy
    Shuang-Yin Lei, Hanjiao Qin, Shui Liu, Jiyao Sheng · 2025 · International Journal of Nanomedicine
36. An Intracellular Peptide Library Screening Platform Identifies Irreversible Covalent Transcription Factor Inhibitors
    Andrew Brennan, Scott Lovell, Keith W. Vance, Jody M. Mason · 2025 · Advanced Science
37. Synthesis and evaluation of biarylquinoline derivatives as novel HIF-1α inhibitors
    Yu‐Chieh Wu, Meng‐Tien Lu, Tai-Hui Lin, Po‐Chen Chu, Chih‐Shiang Chang · 2022 · Bioorganic Chemistry
38. High-throughput enrichment of functional disulfide-rich peptides by droplet microfluidics
    Jing Xie, Kuok Yap, Simon J. de Veer, Selvakumar Edwardraja, Thomas Durek, Matt Trau, David J. Craik, Conan K. L. Wang · 2025 · Lab on a Chip
39. The tetrameric structure of Plasmodium falciparum phosphoglycerate mutase is critical for optimal enzymatic activity
    Ankita Tehlan, Krishanu Bhowmick, Amarjeet Kumar, Naidu Subbarao, Suman Kumar Dhar · 2022 · Journal of Biological Chemistry
40. HIF-2α Inhibits Ameloblast Differentiation via Hey2 in Tooth Development
    S. Kimura, Nobuo Takeshita, Toshihito Oyanagi, Daisuke Seki, Wei Jiang, K. Hidaka, Satoshi Fukumoto, Ichiro Takahashi, Teruko Takano‐Yamamoto · 2022 · Journal of Dental Research
41. Genetically Encoded Whole Cell Biosensor for Drug Discovery of HIF-1 Interaction Inhibitors
    Louis H. Scott, Mark J Wigglesworth, Verena Siewers, Andrew M. Davis, Florian David · 2022 · ACS Synthetic Biology
42. Probing the epigenetic regulation of HIF-1α transcription in developing tissue
    Ishna N. Mistry, Peter J. Smith, David I. Wilson, Ali Tavassoli · 2015 · Molecular BioSystems
43. Tag-like cyclic peptides: Modular affinity elements for protein integration and bioengineering applications
    Zirui Zhu, Andrew Poweleit, Louisa Girard, Wenjun Sun, Haowei Ma, Edouard Collins Nice · 2025 · Bioorganic & Medicinal Chemistry
44. Evaluation of hypoxia inducible factor targeting pharmacological drugs as antileishmanial agents
    Marina Dal'Bó Pelegrini Campioni, Juliana Biar Pereira, Solange dos Santos Costa, Myriam Janeth Salazar-Terreros, Adriana Degrossoli, Selma Giorgio · 2016 · Asian Pacific Journal of Tropical Medicine
45. Head‐to‐tail cyclization of side chain‐protected linear peptides to recapitulate genetically‐encoded cyclized peptides
    Samir Bouayad‐Gervais, Daniel J. St‐Cyr, Mathieu Courcelles, Éric Bonneil, Florence H. Gohard, Pierre Thibault, William C. Earnshaw, Mike Tyers · 2022 · Peptide Science
46. Protein–Protein Interaction Inhibitors in Cancer
    Ian Robert Hardcastle · 2016 · Elsevier eBooks
47. The Discovery of Peptide Macrocycle Rescuers of Pathogenic Protein Misfolding and Aggregation by Integrating SICLOPPS Technology and Ultrahigh-Throughput Screening in Bacteria
    Dafni Chrysanthi Delivoria, Γεώργιος Σκρέτας · 2021 · Methods in molecular biology
48. The Capability to Undergo ACSL4-Mediated Ferroptosis Is Acquired During Brown-like Adipogenesis and Affected by Hypoxia
    Markus Mandl, Elisabeth Heuboeck, Peter Benedikt, Florian Huber, Olga Mamunchak, Sonja Großmann, Michaela Kotnik, Esma Hamzic-Jahic, Charnkamal Singh Bhogal, Anna-Maria Lipp et al. · 2025 · Cells
49. Hypoxia-induced autophagic degradation of HIF-1α attenuates cellular aging and extends mammalian lifespan
    Chen Yang, Zeng Xu, Sha-Tong He, Gen-Jiang Zheng, Jian‐xi Wang, Fazhi Zang, Jin-Quan Hu, Yun‐Hao Wang, Wen-Yu Zhang, Chen-Fei Gao et al. · 2026 · Nature Aging
50. DDX5 enhances HIF‐1 activity by promoting the interaction of HIF‐1α with HIF‐1β and recruiting the resulting heterodimer to its target gene loci
    Yukari Shirai, Tatsuya Suwa, Minoru Kobayashi, Sho Koyasu, Hiroshi Harada · 2023 · Biology of the Cell
51. Tetracycline analogues with a selective inhibitory effect on HIF-1α
    Yassine Bendiabdellah, Khondaker Miraz Rahman, Badarch Uranchimeg, Kazi Sharmin Nahar, Dyeison Antonow, Robert H. Shoemaker, Giovanni Melillo, Giovanna Zinzalla, David E. Thurston · 2014 · MedChemComm
52. Intein-mediated backbone cyclization of entolimod confers enhanced radioprotective activity in mouse models
    Bingyu Ye, Wenlong Shen, Minglei Shi, Yan Zhang, Cunshuan Xu, Zhihu Zhao · 2018 · PeerJ
53. The ‘ABC’ of split-nanoluciferase HIF heterodimerization bioassays: Applications, Benefits & Considerations
    Liesl K. Janssens, Christophe Pol Stove · 2024 · Biochemical Pharmacology
54. Optimized Construction of a Yeast SICLOPPS Library for Unbiased In Vivo Selection of Cyclic Peptides
    Nanna Birkmose, Emilie U. Frydendahl, Charlotte Rohde Knudsen · 2024 · Biochemistry
55. Genetic Selections with SICLOPPS Libraries: Toward the Identification of Novel Protein–Protein Interaction Inhibitors and Chemical Tools
    Francisco Castillo, Ali Tavassoli · 2019 · Methods in molecular biology
56. C-terminal HSP90 Inhibitors Block the HSP90:HIF-1α Interaction and Inhibit the Cellular Hypoxic Response
    Nalin Kataria, Bernadette Kerr, Samantha S. Zaiter, Shelli R. McAlpine, Kristina M. Cook · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
57. Synthesis, Binding Affinity Analysis, and 18F Radiosynthesis of Small‐Molecular‐Weight HIF‐1α‐Binding Compounds
    Jenilee D. Woodfield, Atul Bhardwaj, Cody Bergman, Frank R. Wuest · 2021 · ChemMedChem
58. Hypoxia Inducible Factor‐1α Specific Probe for Tumor Hypoxia Positron Emission Tomography Imaging
    Qian Chen, Teli Liu, Xiaoyi Guo, Qian Zhang, Siqi Hao, Yang Jiang, Xianteng Yang, Nan Li, Hua Zhu, Zhi Yang · 2025 · Journal of Labelled Compounds and Radiopharmaceuticals
59. Macrocyclic peptides as protein–protein interaction modulators: a review
    Erin Ann Sunny Sunny, Sandhya Sadanandan · 2026 · Organic & Biomolecular Chemistry
60. Peptide Therapeutics for Solid Tumors: Functional Classes, AI‐Enhanced Discovery and Clinical Advances
    Jinqiu Liang, Xiaochuan Tang, Haoqi Li, Yan Fang, Feng Jiang · 2026 · Journal of Peptide Science
61. Medical and Biotechnological Aspects
    Jonathan D. Walton · 2018 · Springer eBooks
62. Molecular docking and pharmacophore models to probe binding hypothesis of inhibitors of hypoxia inducible factor-1
    Zaira Rehman, Ishrat Jabeen, Ammad Fahim, Attya Bhatti, Peter C. L. John · 2021 · Journal of Biomolecular Structure and Dynamics
63. Biological and Hybrid Biological/Chemical Strategies in Diversity Generation of Peptidic Macrocycles
    Francesca Vitali, Rudi Fasan · 2017
64. Molecular Technologies for Pseudo‐natural Peptide Synthesis and Discovery of Bioactive Compounds Against Undruggable Targets
    Joseph M. Rogers, Hiroaki Suga · 2019
65. Emerging Role of NO-Mediated Therapeutics
    Cian Michael McCrudden, Helen O. McCarthy · 2015 · Springer eBooks
66. Targeting Hypoxic Adaptations of Cancer Cells: Molecular Mechanisms and Therapeutic Opportunities
    Ceen‐Ming Tang, Jun Qing Yu · 2014 · Springer eBooks
67. Progress in Targeting Epigenetic Readers
    Chun‐wa Chung · 2015 · Royal Society of Chemistry eBooks
68. Iron, Cancer, and Hypoxia-Inducible Factor Signaling
    Xiang Xue, Yatrik Madhukar Shah · 2016 · Elsevier eBooks
69. Study of the aryl hydrocarbon receptor as a target for rational drug design
    Jinghang Xie · 2014 · Scholarly Commons (University of the Pacific)
70. Macrocycles for Protein–Protein Interactions
    Eilidh K. Leitch, Ali Tavassoli · 2017
71. Cell-based assays for identifying, validating and optimizing protein–protein interaction modulators
    Abigail L. Male, Ali Tavassoli · 2013
72. Development of a fluorescent three‐hybrid system for the identification of protein‐protein associators
    Andrew D. Foster, Chun‐wa Chung, Michael M. Hann, Graham L. Simpson, Ali Tavassoli · 2020 · Peptide Science
73. Cyclic Peptides as Chemical Probes
    Luís Serrano, Grace Roper, Akane Kawamura · 2020 · Royal Society of Chemistry eBooks
74. Peer Review #1 of "Intein-mediated backbone cyclization of entolimod confers enhanced radioprotective activity in mouse models (v0.1)"
    2018 · PeerJ
75. Peer Review #2 of "Intein-mediated backbone cyclization of entolimod confers enhanced radioprotective activity in mouse models (v0.1)"
    2018 · PeerJ
76. Basic Reflections on Tumor Hypoxia
    2023 · Royal Society of Chemistry eBooks
77. A novel herbal aromatic essential oil for treating Chemotherapy-Induced Nausea and Vomiting: a mass spectrometry and network pharmacology study of the traditional Chinese medicine formula
    Min Zhan, Yuanfang Sun, Jun Yan, Qiaoxuan Zhang, Liqiao Han, Pengwei Zhang, Haibiao Lin, Zemin Wan, Xue Hong Xiao, Shasha Li et al. · 2024 · Research Square
78. Compound heterozygous PROC mutations cause lipedema in humans
    Jiqiu Wang, Ruikai Yang, Mengshan Ni, Weiqiong Gu, Bin Gu, Juan Zhang, Yinmeng Zhu, Yingying Jia, Zhiyao Xie, Jiafu Li et al. · 2025 · Research Square
79. Deciphering the mechanism and substance basis of Dingxiang Shidi Decoction for the treatment of chemotherapy-induced nausea and vomiting by integrating mass spectrometry, network pharmacology and molecular docking
    Min Zhan, Qian Wang, Jun Yan, Qiao-Xuan Zhang, Li-Qiao Han, Ze-Min Wan, Shasha Li, Xian-Zhang Huang · 2025 · Technology and Health Care
80. Integrating SICLOPPS screening with next-generation sequencing for the discovery of cyclic peptide modulators of protein–protein interactions
    Juan Antonio Sarmiento Muro, Ali Tavassoli · 2025 · Methods in enzymology on CD-ROM/Methods in enzymology
81. Peptide Discovery: Lead Generation
    Yvonne Angell, Wendy J. Hartsock, Hans Melo, Timothy M. Reichart · 2025 · Peptide Science
82. Protein-protein interaction inhibitors in cancer
    Ian Robert Hardcastle, Jennyfer Goujon-Ricci, William Isaac Thompson · 2026 · Elsevier eBooks
83. Ciblage thérapeutique de la réponse au stress cellulaire dans l'ostéosarcome
    Brice Moukengué · 2019 · theses.fr (ABES)
84. Cyclic Peptide PROTACs Restore VHL-Mediated HIF-1α Degradation in Hypoxia
    Alexander McDermott, Reece M. Gardner, Monika Papayova, Agnieszka Beata Wisniewska, Cyrielle Doigneaux, Soran Mohammed, Ali Tavassoli · 2026 · Journal of the American Chemical Society
85. De Novo Discovery of Bioactive Cyclic Peptides via Cellular Selection of Genetically Encoded Libraries
    Linwei Yang, Abhijit Behera, Hannah J. Meyers, Tina Wang · 2026 · ChemBioChem
86. BindingDB Entry 50009047: Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications.
    BindingDB · 2021 · UC San Diego
87. BindingDB Entry 50008584: New Modalities, Technologies, and Partnerships in Probe and Lead Generation: Enabling a Mode-of-Action Centric Paradigm.
    BindingDB · 2021 · UC San Diego
88. BindingDB Entry 50015977: Cyclic Peptide Screening Methods for Preclinical Drug Discovery.
    BindingDB · 2023 · UC San Diego
89. BindingDB Entry 50015429: Potent Inhibition of HIF1α and p300 Interaction by a Constrained Peptide Derived from CITED2.
    BindingDB · 2023 · UC San Diego
90. BindingDB Entry 50010309: Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.
    BindingDB · 2021 · UC San Diego
91. BindingDB Entry 50002640: A genetically selected cyclic peptide inhibitor of BCL6 homodimerization.
    BindingDB · 2020 · UC San Diego